[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2675 Introduced in House (IH)]
<DOC>
116th CONGRESS
1st Session
H. R. 2675
To provide for a Department of Veterans Affairs policy on medicinal
cannabis, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 10, 2019
Mr. Moulton (for himself, Mr. Gaetz, Mr. Soto, Mr. Johnson of Georgia,
and Mr. Crist) introduced the following bill; which was referred to the
Committee on Veterans' Affairs
_______________________________________________________________________
A BILL
To provide for a Department of Veterans Affairs policy on medicinal
cannabis, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Department of Veterans Affairs
Policy for Medicinal Cannabis Use Act of 2019''.
SEC. 2. DEPARTMENT OF VETERANS AFFAIRS POLICY ON MEDICINAL CANNABIS.
(a) Policy.--The policy of the Department of Veterans Affairs on
medicinal cannabis is as follows:
(1) Veterans are encouraged to discuss their medicinal
cannabis use with their health care providers without fear of
negative repercussions.
(2) Veterans shall not be denied any benefit under the laws
administered by the Secretary of Veterans Affairs by reason of
cannabis use.
(3) The participation of a veteran in a State-legal
marijuana program shall not affect the veteran's eligibility
for care and services furnished by the Department of Veterans
Affairs.
(4) The use or possession of cannabis is prohibited on all
Department property and in all Department facilities pursuant
to Federal law, which applies at such locations and not the
laws of the State where the property or facility is located.
(5) Department medical providers shall honor the desires of
their patients to seek alternative forms of treatment.
(6) The Department of Veterans Affairs acknowledges
medicinal cannabis use may be a legitimate alternative
treatment and a Department medical provider will not recommend
a veteran for drug addiction treatment solely by reason of
medicinal cannabis use.
(7) Department medical providers are permitted to discuss
cannabis use as part of comprehensive care planning and may
adjust treatment plans as necessary. Treatment adjustment
should be relevant and a veteran should have the freedom to
seek a second opinion if the veteran feels the change is not
fair.
(8) Department medical providers will annotate a veteran's
cannabis use in the medical record of the veteran in order to
have the information available in treatment planning. As with
all clinical information, this is part of the confidential
medical record and protected under patient privacy and
confidentiality laws and regulations. Department medical
providers will not record that a patient has a marijuana
addiction problem in their medical record if the patient is
responsibly using medicinal cannabis.
(9) Department clinicians shall follow Federal laws and
regulations relating to medicinal cannabis.
(10) Department medical providers may not be fired nor have
any other adverse personnel action taken against them for
discussing cannabis use with their patients.
(11) Department scientists may conduct research on cannabis
benefits and risks under regulatory approval.
(12) Department medical providers may not dissuade
participation in non-Department medicinal cannabis research.
(b) Dissemination of Policy.--The Secretary of Veterans Affairs
shall disseminate the policy under subsection (a) widely, including by
displaying such policy prominently in all Department of Veterans
Affairs hospitals and clinics and online.
(c) Repeal in Event of Federal Legalization.--If the use of
medicinal cannabis becomes legal under Federal law, the requirement
under subsection (a)(4) shall be repealed.
<all>